Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine.
The natural alkaloid berberine has been ascribed numerous health benefits including lipid and cholesterol reduction and improved insulin sensitivity in diabetics. However, oral (PO) administration of berberine is hindered by poor bioavailability and increasing dose often elicits gastro-intestinal si...
Main Authors: | Beth Buchanan, Qingfang Meng, Mathieu-Marc Poulin, Jonathan Zuccolo, Chike Godwin Azike, Joseph Gabriele, David Charles Baranowski |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5868852?pdf=render |
Similar Items
-
A reliable and validated LC-MS/MS method for the simultaneous quantification of 4 cannabinoids in 40 consumer products.
by: Qingfang Meng, et al.
Published: (2018-01-01) -
Inhibitory effects and mechanism of dihydroberberine on hERG channels expressed in HEK293 cells.
by: Dahai Yu, et al.
Published: (2017-01-01) -
Anti-Hyperuricemic and Nephroprotective Effects of Dihydroberberine in Potassium Oxonate- and Hypoxanthine-Induced Hyperuricemic Mice
by: Lieqiang Xu, et al.
Published: (2021-04-01) -
Synthesis of new dihydroberberine and tetrahydroberberine analogues and evaluation of their antiproliferative activity on NCI-H1975 cells
by: Giacomo Mari, et al.
Published: (2020-07-01) -
Penetration and efficacy of transdermal NSAIDs in a model of acute joint inflammation
by: Baranowski DC, et al.
Published: (2018-11-01)